Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and FDA Moves to Reevaluate Several Peptides American Med Spa Association